Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and neostigmine

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with neostigmine in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(neostigmine)
Trials
(neostigmine)
Recent Studies (post-2010) (neostigmine)
9,1561875525,020454637

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)neostigmine (IC50)
AcetylcholinesteraseElectrophorus electricus (electric eel)2.54
CholinesteraseHomo sapiens (human)0.45
AcetylcholinesteraseHomo sapiens (human)1.1
CholinesteraseEquus caballus (horse)2.93

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jouët, P; Sarna, SK1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and neostigmine

ArticleYear
Platelet-activating factor (PAF) stimulates giant migrating contractions during ileal inflammation.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 279, Issue:1

    Topics: Animals; Calcium; Dogs; Female; Ileitis; Ileum; Male; Methacholine Chloride; Motilin; Muscle Contraction; Neostigmine; Platelet Activating Factor; Substance P

1996